Can delayed/extended-release methylphenidate allow for once daily evening dosing in ADHD?
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, April 2, 2019--A new three-part study showed that a delayed-release, extended-release ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, April 2, 2019--A new three-part study showed that a delayed-release, extended-release ...
ATLANTA -- The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in ...
WHAT: The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination ...
ATLANTA -- Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with ...
ATLANTA -- The investigational anticancer therapeutic LOXO-195 (now known as BAY 2731954), which targets a family of proteins called TRKs, ...
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that ...
Credit: University of Colorado Cancer Center A study by University of Colorado Cancer Center and Rain Therapeutics, Inc. presented at ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, April 1, 2019--Modern medicines have positively contributed to public health and ...
Credit: University of Colorado Cancer Center A cancer cell is like a racecar, speeding through the process of cellular replication. ...
Credit: University of Colorado Cancer Center Many cancers are relatively harmless at their site of origin, and it is only ...
Rehab gloveCredit: UT Arlington The University of Texas at Arlington Research Institute is making flexible soft robotic gloves that will ...
ATLANTA -- A combination of the experimental histone deacetylase (HDAC) inhibitor entinostat with the anti-PD-1 therapeutic pembrolizumab (Keytruda) showed clinical ...
Metformin can halve the risk of late miscarriage and preterm births for women with polycystic ovary syndrome (PCOS). PCOS occurs ...
ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia ...
ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with ...
ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced ...
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to ...
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who ...
ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among ...
ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.